Jimilihan Simayi

Jimilihan Simayi

Auto-generated profile, based on publicly available information

Jimilihan Simayi

Department of Pharmacology, Xinjiang Medical University, 830011 Urumqi, Xinjiang, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JSJimilihan Simayi
Jimilihan Simayi
AAAbulaiti Abulizi
Abulaiti Abulizi
MNMaimaitiming Nuermaimaiti
Maimaitiming Nuermaimaiti
Nawaz KhanNawaz Khan
Nawaz Khan
SHSendaer Hailati
Sendaer Hailati
AWAiniwaer Wumaier
Ainiwaer Wumaier
Cydonia oblonga Mill. (COM), mature fruit of genus Rosaceae, is consumed as a kind of traditional Chinese medicinal herb. Previous studies have shown that the components in COM extract have antioxidant, anti‐inflammatory, blood pressure‐lowering, blood lipid‐lowering, antithrombotic, and other biological activities. However, the quality markers (Q‐markers) of atherosclerosis (AS) have not been elucidated. The Q‐marker is based on the five core principles of traceability, transferability, specificity, measurability, validity, and prescription dispensing. In this study, the quality markers of quince were investigated by applying the ultraperformance liquid chromatography‐time‐of‐flight mass spectrometry (UHPLC/Q‐TOF‐MS/MS) method and network pharmacology method to highlight the three core elements which are, respectively, traceability transmission, measurability, and validity. At the first step, 72 components were identified by applying the ultraperformance liquid chromatography‐time‐of‐flight mass spectrometry (UHPLC/Q‐TOF‐MS/MS) method. In the next step, 46 candidate components of COM anti‐AS were obtained by network pharmacology, and then, 27 active components were filtered with the molecular docking assay. Finally, the 27 active components were intersected with 10 active components obtained by mass transfer and traceable quality markers. Four anti‐AS Q‐markers of COM were identified, including caffeic acid, chlorogenic acid, ellagic acid, and vanillic acid, which provided a reference for the quality control of quince. The methods and strategies can also be applied to other traditional Chinese medicines and their compound preparations, providing new ideas on the quantitative evaluation and identification of quality markers.

1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JSJimilihan Simayi
Jimilihan Simayi
BABayinsang
Bayinsang
MNMaimaitiming Nuermaimaiti
Maimaitiming Nuermaimaiti
SHSendaer Hailati
Sendaer Hailati
MHMengyuan Han
Mengyuan Han
WZWenting Zhou
Wenting Zhou
Background. Ocimum basilicum L. (OBL) is mainly used to treat neurological diseases in China. The preliminary work of this group showed that OBL improves cognitive impairment in Alzheimer’s disease (AD). However, the underlying pharmacological mechanism remains unclear. Methods. The components of OBL were compiled by literature search, and their active ingredients were screened by online database. The drug targets of OBL in the treatment of AD were predicted and analyzed using information derived from sources such as the SwissTargetPrediction tool. And through the network visual analysis function of Cytoscape software and protein‐protein interaction analysis (PPI), the core targets of OBL treatment of AD are predicted. Furthermore, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were employed to analyze the related signaling pathways affected by OBL. Moreover, AutoDock software was used to assess the potential binding affinity between the core targets and the active compounds. Subsequently, in vivo experiment was conducted to verify the findings of network pharmacology. Results. A total of 35 active compounds and 188 targets of OBL were screened, of which 43 common targets were related to AD. The active compounds of 35 OBLs induced 118 GO and 78 KEGG. The results of PPI and network topology parameter analysis show that targets such as MAPK1, GSK3B, NR3C2, ESR1, and EGFR are known as the core targets for the treatment of AD by OBL and are docked with the active ingredients of OBL. Molecular docking results suggest that diterbutyl phthalate (DBP) may be the main active component of OBL for the treatment of AD. Flow cytometry analysis results showed that apoptosis decreased with increasing DBP dose. In addition, DBP significantly decreased the levels of lactate dehydrogenase (LDH) and reactive oxygen species (ROS) in the supernatant of Aβ25-35‐induced injury HT22 cell cultures, and it can be speculated that DBP has the ability to protect the stability of injured neuronal cells and improve the permeability of cell membranes, thus stabilizing the intracellular environment. Mechanistically, DBP may increase the mRNA levels of AKT, GSK‐3β, etc. in AD cell models and regulate the phosphorylation of AKT/GSK‐3β pathway‐related. Conclusions. Conclusively, our study suggests that DBP, the main active component of OBL, has potential in the prevention or treatment of AD.